Free Trial
NASDAQ:SEER

Seer Q2 2025 Earnings Report

Seer logo
$2.13 +0.01 (+0.47%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$2.13 0.00 (0.00%)
As of 08/1/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Seer EPS Results

Actual EPS
N/A
Consensus EPS
-$0.39
Beat/Miss
N/A
One Year Ago EPS
N/A

Seer Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.75 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Seer Announcement Details

Quarter
Q2 2025
Time
After Market Closes
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Seer Earnings Headlines

Microsoft's Next Big Bet?
Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-free energy. Bill Gates calls it “abundant” and is backing four separate startups in the space. While most of these plays are off-limits to everyday investors, a little-known backdoor could give you access to one tiny company leading the charge—and it’s publicly traded.
Seer Faces Nasdaq Compliance Challenge After Annual Meeting
Seer (NASDAQ:SEER) Stock Price Down 0.9% - Should You Sell?
See More Seer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email.

About Seer

Seer (NASDAQ:SEER), a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

View Seer Profile

More Earnings Resources from MarketBeat